financetom
Business
financetom
/
Business
/
Strategic Education's Q3 Adjusted Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Strategic Education's Q3 Adjusted Earnings, Revenue Rise
Nov 6, 2025 6:35 AM

09:06 AM EST, 11/06/2025 (MT Newswires) -- Strategic Education ( STRA ) reported Q3 adjusted earnings Thursday of $1.63 per diluted share, up from $1.16 a year earlier.

Three analysts polled by FactSet expected $1.30.

Revenue for the quarter ended Sept. 30 was $319.9 million, up from $306 million a year earlier.

Three analysts surveyed by FactSet expected $314.7 million.

The company's shares were up 3% in recent Thursday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Novo Nordisk gets UK approval for using weight-loss drug to reduce heart risks
Novo Nordisk gets UK approval for using weight-loss drug to reduce heart risks
Jul 23, 2024
July 23 (Reuters) - Novo Nordisk's weight-loss drug Wegovy has secured the UK regulator's approval for its use to reduce the risk of overweight and obese adults suffering serious heart problems or strokes, the agency said on Tuesday. (Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur) ...
Tivic Health Systems Gets 3 New Patents in US, Europe
Tivic Health Systems Gets 3 New Patents in US, Europe
Jul 23, 2024
10:31 AM EDT, 07/23/2024 (MT Newswires) -- Tivic Health Systems ( TIVC ) said Tuesday it has received three new patents in the US and Europe. The company said it has received the patents Sinus Treatment Device With Adaptive Circuit from the European Patent Office and Adaptive Trigger for a Microcurrent Stimulation Device from Europe and the US Patent and...
Ainos Enrolls First Subject in Taiwanese Trial for VELDONA-Based Feline FCGS Treatment
Ainos Enrolls First Subject in Taiwanese Trial for VELDONA-Based Feline FCGS Treatment
Jul 23, 2024
10:31 AM EDT, 07/23/2024 (MT Newswires) -- Ainos (AIMD) said Tuesday it enrolled the first subject in its Taiwanese clinical trial of a VELDONA-based animal drug for treating feline chronic gingivostomatitis. The first subject is scheduled to receive the dose on Friday, the company said. FCGS is a severe and painful chronic oral disease in cats, marked by inflammation or...
Nano Nuclear Files Provisional Patent Applications For Annular Linear Induction Pump Technology
Nano Nuclear Files Provisional Patent Applications For Annular Linear Induction Pump Technology
Jul 23, 2024
10:30 AM EDT, 07/23/2024 (MT Newswires) -- Nano Nuclear Energy ( NNE ) said Tuesday it has filed a series of provisional patent applications with the US Patent and Trademark Office to secure intellectual property protection for its recently acquired annular linear induction pump technology. The pump is a key enabling technology for its ODIN microreactor in development and the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved